Cannabisin B

Cannabisin B
Product Name Cannabisin B
CAS No.: 144506-17-2
Catalog No.: CFN95268
Molecular Formula: C34H32N2O8
Molecular Weight: 596.6 g/mol
Purity: >=98%
Type of Compound: Alkaloids
Physical Desc.: Powder
Targets: Akt | mTOR
Source: The herbs of Cannabis sativa L.
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Price: $413/5mg
Cannabisin B possesses considerable antiproliferative activity and that it may be utilised as a promising chemopreventive agent against hepatoblastoma disease. It induces autophagic cell death by inhibiting the AKT/mTOR pathway and S phase cell cycle arrest in HepG2 cell.
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • Environ Toxicol.2023, 38(7):1641-1650.
  • Environ Toxicol.2019, 34(12):1354-1362
  • Metabolites2022, 12(6),507.
  • Front Pharmacol.2021, 12:764297.
  • Srinagarind Medical Journal2017, 32(1)
  • Journal of Apiculture2023.38(3):249-254.
  • Life Sci.2018, 209:498-506
  • Environ Toxicol.2024, 39(3):1556-1566.
  • Molecules.2023, 28(8):3474.
  • Malaysian J of Fundamental and Applied Sciences 2018, 14(3):368-373
  • Auranamide

    Catalog No: CFN95804
    CAS No: 740813-53-0
    Price: $413/5mg
    Cannabisin B

    Catalog No: CFN95268
    CAS No: 144506-17-2
    Price: $413/5mg
    Cannabisin D

    Catalog No: CFN90405
    CAS No: 144506-19-4
    Price: $488/5 mg
    Cannabisin P

    Catalog No: CFN95456
    CAS No: 2756983-19-2
    Price: $318/5mg
    Cannabisin M

    Catalog No: CFN95436
    CAS No: 1831134-13-4
    Price: $318/5mg
    Grossamide

    Catalog No: CFN97672
    CAS No: 80510-06-1
    Price: $318/5mg
    Paprazine

    Catalog No: CFN92967
    CAS No: 36417-86-4
    Price: $268/10mg
    N-p-Coumaroyloctopamine

    Catalog No: CFN97706
    CAS No: 66648-45-1
    Price: $218/10mg
    Tamgermanetin

    Catalog No: CFN92966
    CAS No: 640235-90-1
    Price: $318/5mg
    Cis-N-Feruloyltyramine

    Catalog No: CFN92826
    CAS No: 80510-09-4
    Price: $318/5mg
    Food Chemistry, 2013,138(2-3):1034-41.
    Cannabisin B induces autophagic cell death by inhibiting the AKT/mTOR pathway and S phase cell cycle arrest in HepG2 cells.[Reference: WebLink]

    METHODS AND RESULTS:
    This study investigates the anticancer properties of Cannabisin B, purified from hempseed hull, in HepG2 human hepatoblastoma cells. The results indicate that Cannabisin B significantly inhibited cell proliferation by inducing autophagic cell death rather than typical apoptosis. Cell viability transiently increased upon the addition of a low concentration of Cannabisin B but decreased upon the addition of high concentrations. Cannabisin B-induced changes in cell viability were completely inhibited by pre-treatment with 3-methyladenine (3-MA), indicating that the induction of autophagy by Cannabisin B caused cell death. Additionally, Cannabisin B induced S phase cell cycle arrest in a dose-dependent manner. Moreover, Cannabisin B was found to inhibit survival signaling by blocking the activation of AKT and down-stream targets of the mammalian target of rapamycin (mTOR).
    CONCLUSIONS:
    These findings suggest that Cannabisin B possesses considerable antiproliferative activity and that it may be utilised as a promising chemopreventive agent against hepatoblastoma disease.
    3''-Galloylquercitrin

    Catalog No: CFN95048
    CAS No: 503446-90-0
    Price: $368/5mg
    Magnaldehyde B

    Catalog No: CFN95075
    CAS No: 92829-72-6
    Price: $318/5mg
    Patulitrin

    Catalog No: CFN95153
    CAS No: 19833-25-1
    Price: $318/10mg
    Marginatoxin

    Catalog No: CFN95174
    CAS No: 1422536-56-8
    Price: $318/10mg
    (3E,5E,11E)-tridecatriene-7,9-diyne-1,2-diacetate

    Catalog No: CFN95191
    CAS No: 94753-06-7
    Price: $318/5mg
    5-Hydroxy-7,8-dimethoxy (2R)-flavanone-5-O-beta-D-glucopyranoside

    Catalog No: CFN95209
    CAS No: 942626-74-6
    Price: $318/10mg
    Stevia impurity (13-[(2-O-6-deoxy-beta-D-glucopyranosyl-3-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy]ent-kaur-16-en-19-oic acid beta-D-glucopyranosyl ester)

    Catalog No: CFN95229
    CAS No: 1309929-72-3
    Price: $463/5mg
    New compound 5

    Catalog No: CFN95258
    CAS No: N/A
    Price: $413/5mg
    New compound 8

    Catalog No: CFN95341
    CAS No: N/A
    Price: $318/5mg
    8-epi-Confertin

    Catalog No: CFN95509
    CAS No: 110115-60-1
    Price: $318/5mg